Cipla does not disclose pricing of drug, Hetero to supply its version of Remdesivir at Rs. 5,000- Rs. 6,000 per vial New Delhi: Drugmakers Cipla and Hetero yesterday said they had launched generic versions of Remdesivir to treat COVID-19 patients. Both the companies received regulatory approval of Remdesivir from the Drug Controller General of India…
Recent Comments